This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: Setanaxib + Pembro in Recurrent or Metastatic HNSCC

89 views
September 20, 2024
Comments 0
Login to view comments. Click here to Login